NewTimeSpace News: Sihuan Pharmaceutical Holdings Group Ltd. (00460.HK) announced that the Phase III clinical study of self-developed innovative drug Anaprazole Sodium Enteric-coated Tablets (brand name: Anjiuwei®) from its non-wholly-owned subsidiary Xuanzhu Biologics, evaluating bismuth quadruple therapy containing Anaprazole Sodium for Helicobacter pylori eradication, has completed the first patient dosing, marking the official launch of this pivotal registrational clinical trial.
NewTimeSpace News: Guangzhou Innogen Pharmaceutical Group Co., Ltd. (02591.HK) announced that the Group obtained approval from the NMPA on 17 June 2026 to launch an Ib-stage clinical trial of Efsubaglutide Alfa for the treatment of adolescent obesity. The trial is scheduled to commence in July 2026, with a planned enrollment of approximately 36 participants.
NewTimeSpace (newtimespace.com) News: On June 22, 2026, the robot concept sector fluctuated and weakened. Xiaomi Corporation-W (01810.HK) continued to open lower and move downward. As of 13:05 PM, the company's share price was quoted at HK$23.600, down 3.99%.
NewTimeSpace News: On June 22, 2026, RoboSense(02498.HK) traded lower in the morning session. As at 11:25, its intraday price stood at HK$22.72, representing a decline of 4.38%. Cumulative deliveries of RoboSense’s E-platform solid-state digital LiDAR have surpassed 300,000 units.
NewTimeSpace (newtimespace.com) News, On June 22, 2026, large model concept stocks in the Hong Kong stock market collectively strengthened. Mininglamp Technology (2718.HK) opened higher and continued to push upward during morning trading. As of 9:53 AM, the company's share price was quoted at HK$245.400, up 16.19%.
NewTimeSpace News: Shanghai MicroPort MedBot (Group) Co., Ltd. (02252.HK) announced that the self-developed Toumai laparoscopic surgical robot remote full-department application has obtained EU CE certification. The system supports remote robotic surgeries for urology, general surgery, thoracic surgery and gynecology, making it the world’s first remote surgical robot to receive EU CE certification.
NewTimeSpace News: Jenscare Scientific Co., Ltd. (09877.HK) announced that its Ken-Valve transcatheter aortic valve system has obtained approval from the Hong Kong Department of Health. The Company is actively advancing the commercialization of this product in Hong Kong.
NewTimeSpace News: In a voluntary announcement dated June 21, Xuanzhu Biology revealed that the Phase III clinical study of self-developed Anaprazole Sodium Enteric-coated Tablets (Anjiuwei®) for Helicobacter pylori eradication has completed first patient enrollment.
On June 18, Hong Kong stocks drifted lower, yet the LLM and domestic computing power supply chains bucked the broader market decline to register substantial gains, led by ZHIPU AI surging over 26% and MiniMax jumping 12.3%. Iluvatar CoreX skyrocketed 21% amid reports of a massive chip procurement pipeline from ByteDance. The rally was primarily fueled by regulatory catalysts, as the SSE formally issued guidelines extending the STAR Market's fifth listing standard to pre-revenue AI LLM firms, sparking a sector-wide valuation rerate. Consequently, ZHIPU AI’s domestic listing process accelerated, with its IPO status upgraded to "Tutoring Acceptance." Meanwhile, the primary market witnessed a blockbuster Series A round by DeepSeek, drawing multi-billion RMB commitments from its founder, Tencent, and CATL.
NewTimeSpace News: On June 18, 2026, XPENG-W(09868.HK) weakened in afternoon trading. As of 15:31, its intraday quotation stood at HK$51.3, representing a decline of 3.84%. The 13th OTA upgrade for MONA M03 has been fully deployed to all vehicles.
NewTimeSpace (newtimespace.com) News: On June 18, 2026, the chip sector continued to strengthen as SMIC (00981.HK) fluctuated upward. As of 1:43 PM, the company's share price was quoted at HK$78.250, up 3.30%.
the Shanghai Stock Exchange (SSE) issued the Application Guidelines No. 10 for Issuance and Listing Review Rules of the Shanghai Stock Exchange — Application of the Fifth Set of Listing Standards of the Science and Technology Innovation Board by Artificial Intelligence Large Model Enterprises (hereinafter referred to as the "Guidelines No. 10")This expansion into the AI large model sector opens up a direct A-share listing channel for a massive number of high-quality large model enterprises that have not yet turned a profit but possess core technologies.
Newtimespace.com reports: Crealights Technology (1191.HK) launches its global offering of approximately 13.43 million H-shares at an offer price of HK$114.00 per share. The Hong Kong public subscription runs from June 18 to June 24, with an expected listing date of June 29. Huatai International serves as the sole sponsor.
NewTimeSpace News: Fosun Pharma announced on June 17 that its controlled subsidiary Henlius has received approval from the National Medical Products Administration (NMPA) to conduct Phase I clinical trials for its self-developed HLX3902 Injection (STEAP1×CD3×CD28 trispecific antibody) in the treatment of metastatic castration-resistant prostate cancer and other advanced solid tumors.
NewTimeSpace News: Shanghai Henlius Biotech, Ltd. (02696.HK) announced on 17 June that the Phase I clinical trial application for self-developed HLX3902 Injection, a STEAP1xCD3xCD28 trispecific antibody, has been approved by NMPA for metastatic castration-resistant prostate cancer (mCRPC) and other advanced solid tumors. The product simultaneously targets STEAP1, CD3 and CD28 to boost T-cell anti-tumor activity, with promising anti-tumor efficacy and safety demonstrated in preclinical studies. No trispecific antibodies targeting the three above antigens have been launched globally to date. The Company cautions there is uncertainty over successful R&D and commercialization of HLX3902. The candidate also obtained Australian clinical trial notification clearance in May 2026.
On June 17, Hong Kong stocks saw narrow consolidation, but the LLM and semiconductor supply chains erupted. ZHIPU AI surged over 12% following the launch and open-sourcing of its GLM-5.2 flagship model, which ranked first globally on the Code Arena benchmark. KUAISHOU-W jumped 7.3% on rumors of a USD 2 billion financing round for Kling AI, while the memory and PCB sectors soared amid price hikes and shortage forecasts. In major industry developments, the CSRC expanded the STAR Market's fifth listing standard to accommodate pre-revenue AI LLM companies, clearing regulatory hurdles for IPOs. Meanwhile, to mitigate soaring compute costs, Microsoft's Copilot Cowork is pivoting to usage-based pricing and exploring cost-effective open-source alternatives like DeepSeek V4.
